Janux Therapeutics, Inc.
JANX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001817713
No open-market purchases or sales by Janux Therapeutics, Inc. insiders were filed in the last 90 days; 197 institutions reported holding it in 13F filings for Q2 2026, worth $933.4M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Janux Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +1 vs. Q4 2021
- Shares held
- 28.4M
- +891.5K (+3.2%) vs. Q4 2021
- Total value
- $407.1M
- −$134.5M (−24.8%) vs. Q4 2021
- New holders
- 5
- 23 more added
- Sold out
- 4
- 10 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JANX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 197 | $933.4M |
| Q1 2026 | 190 | $827.8M |
| Q4 2025 | 176 | $860.0M |
| Q3 2025 | 174 | $1.59B |
| Q2 2025 | 174 | $1.51B |
| Q1 2025 | 181 | $1.81B |
| Q4 2024 | 216 | $3.43B |
| Q3 2024 | 160 | $2.07B |
| Q2 2024 | 155 | $1.87B |
| Q1 2024 | 121 | $1.59B |
| Q4 2023 | 64 | $359.5M |
| Q3 2023 | 57 | $354.0M |
| Q2 2023 | 54 | $362.1M |
| Q1 2023 | 48 | $369.5M |
| Q4 2022 | 50 | $381.3M |
| Q3 2022 | 49 | $400.3M |
| Q2 2022 | 44 | $353.0M |
| Q1 2022 | 47 | $407.1M |
| Q4 2021 | 46 | $541.6M |
| Q3 2021 | 45 | $571.2M |
| Q2 2021 | 30 | $614.5M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Janux Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 8,670,644 | $124.3M | 2.71% | 00.0% | Unchanged |
| FMR LLC | 5,676,926 | $81.4M | 0.01% | +685,524+13.7% | Added |
| OrbiMed Advisors LLC | 2,836,386 | $40.7M | 0.66% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 2,339,146 | $33.5M | 0.02% | −61,747−2.6% | Reduced |
| Citadel Advisors LLC | 1,853,432 | $26.6M | 0.03% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 1,421,319 | $20.4M | 0.64% | +9,344+0.7% | Added |
| BlackRock Inc. | 1,161,721 | $16.7M | 0.00% | +153,460+15.2% | Added |
| BVF Inc | 1,142,340 | $16.4M | 0.66% | +125,026+12.3% | Added |
| Vanguard Group Inc | 565,979 | $8.12M | 0.00% | +32,908+6.2% | Added |
| 5AM Venture Management, LLC | 446,266 | $6.40M | 1.40% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 411,871 | $5.91M | 1.49% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 400,000 | $5.74M | 0.01% | 00.0% | Unchanged |
| Woodline Partners LP | 278,323 | $3.99M | 0.07% | +480.0% | Added |
| Geode Capital Management, LLC | 275,231 | $3.95M | 0.00% | +54,704+24.8% | Added |
| State Street Corp | 241,998 | $3.47M | 0.00% | +30,432+14.4% | Added |
| Cerity Partners LLC | 150,933 | $2.16M | 0.03% | 00.0% | Unchanged |
| Northern Trust Corp | 140,247 | $2.01M | 0.00% | +24,752+21.4% | Added |
| Bank of New York Mellon Corp | 46,001 | $660.0K | 0.00% | +9,464+25.9% | Added |
| Charles Schwab Investment Management Inc | 44,400 | $637.0K | 0.00% | +10,454+30.8% | Added |
| Bank of America Corp | 41,159 | $590.0K | 0.00% | +33,525+439.2% | Added |
| Parkwood LLC | 28,258 | $405.0K | 0.07% | −3,870−12.0% | Reduced |
| Morgan Stanley | 27,743 | $398.0K | 0.00% | +13,264+91.6% | Added |
| Nuveen Asset Management, LLC | 25,660 | $392.0K | 0.00% | +6,203+31.9% | Added |
| Goldman Sachs Group Inc | 17,934 | $257.0K | 0.00% | +3,186+21.6% | Added |
| JPMorgan Chase & Co | 17,926 | $256.0K | 0.00% | +4,638+34.9% | Added |
| State of Wisconsin Investment Board | 17,700 | $254.0K | 0.00% | +17,700 | New |
| Rhumbline Advisers | 16,216 | $233.0K | 0.00% | +5,179+46.9% | Added |
| New York State Common Retirement Fund | 15,521 | $223.0K | 0.00% | +6,000+63.0% | Added |
| D. E. Shaw & Co., Inc. | 11,480 | $165.0K | 0.00% | −16,291−58.7% | Reduced |
| MetLife Investment Management | 10,614 | $152.2K | 0.00% | +5,312+100.2% | Added |
| Deutsche Bank AG | 10,598 | $152.0K | 0.00% | +1,980+23.0% | Added |
| American International Group, Inc. | 8,813 | $126.0K | 0.00% | +1,782+25.3% | Added |
| California State Teachers Retirement System | 7,579 | $109.0K | 0.00% | +430+6.0% | Added |
| Wells Fargo & Company | 4,742 | $68.0K | 0.00% | −3,481−42.3% | Reduced |
| Allspring Global Investments Holdings, LLC | 4,742 | $68.0K | 0.00% | −615−11.5% | Reduced |
| UBS Group AG | 3,500 | $50.0K | 0.00% | −185−5.0% | Reduced |
| Barclays PLC | 2,948 | $42.0K | 0.00% | +2,948 | New |
| Amalgamated Bank | 1,928 | $28.0K | 0.00% | +1,928 | New |
| Amalgamated Financial Corp. | 1,928 | $28.0K | 0.00% | +1,928 | New |
| Citigroup Inc | 1,850 | $27.0K | 0.00% | −2,934−61.3% | Reduced |
| Legal & General Group Plc | 1,700 | $24.0K | 0.00% | +461+37.2% | Added |
| Metropolitan Life Insurance Co | 1,382 | $19.8K | 0.00% | −2,629−65.5% | Reduced |
| Tower Research Capital LLC (TRC) | 1,242 | $18.0K | 0.00% | −142−10.3% | Reduced |
| Royal Bank of Canada | 1,092 | $16.0K | 0.00% | −1,860−63.0% | Reduced |
| Ameritas Investment Partners, Inc. | 1,014 | $15.0K | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 121 | $2.00K | 0.00% | 00.0% | Unchanged |
| Kayne Anderson Rudnick Investment Management LLC | 42 | $1.00K | 0.00% | +42 | New |
| Logos Global Management LP | 0 | $0 | 0.00% | −185,196−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −45,000−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −15,746−100.0% | Sold out |
| Chicago Partners Investment Group LLC | 0 | $0 | 0.00% | −11,380−100.0% | Sold out |